Effects of omalizumab therapy on peripheral nerve functions: short observational study
POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.36, sa.2, ss.211-216, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 36 Sayı: 2
- Basım Tarihi: 2019
- Doi Numarası: 10.5114/ada.2018.74834
- Dergi Adı: POSTEPY DERMATOLOGII I ALERGOLOGII
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.211-216
- Anahtar Kelimeler: chronic urticaria, omalizumab, neuropathy, INFLAMMATORY DEMYELINATING POLYNEUROPATHY, SAFETY, TOLERABILITY, NEUROPATHY, URTICARIA, DIAGNOSIS, PATIENT
- Van Yüzüncü Yıl Üniversitesi Adresli: Evet
Özet
Introduction: Peripheral neuropathy (PN) is a common neurological condition causing symmetrical and diffuse damage in nerves. The etiology of PN includes systemic diseases, toxic exposure, medications, infections, and hereditary diseases. Omalizumab is a humanized monoclonal anti-IgE antibody that exerts its activity by binding to free IgE in circulation.